Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 15, 2019
Pharmacy Choice - News - Generic Drugs - February 15, 2019

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 59     Next >>     Go To Page:

2/15/19 - ALKERMES PLC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
The following should be read in conjunction with our consolidated financial statements and related notes beginning on page F 1 of this Annual Report. We earn revenue on net sales of VIVITROL, ARISTADA and ARISTADA INITIO, which are proprietary products that we manufacture, market and sell in the U.S., and manufacturing and/or royalty revenues on
2/15/19 - Armed Men Attack Indian Pharmaceutical Executive in Moscow [Moscow Times (Russia)]
An Indian national who heads a pharmaceutical company in Russia has been reportedly hospitalized after falling victim to an armed attack in Moscow. Four unknown assailants beat Jyoti Loomba and his driver with bats on the southeastern outskirts of Moscow Thursday evening, a police source told the RBC news website. They then shot Loomba several time
2/15/19 - Infliximab Market to Record Exponential Growth by 2026
Albany, NY 02/15/2019 Biosimilars are biological products that are similar to FDA- approved drug known as branded drug. Biosimilars are drugs licensed by the European Medicines Agency and the U.S. FDA. Infliximab is a monoclonal antibody first manufactured by Janssen Biotech, Inc. in collaboration with Merck& Co. The U.S. Food and Drug Admini
2/15/19 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition
We've been taking new policy steps at the FDA to support downward pressure on drug prices by helping to clear a path for more efficient generic development. We're working to reduce barriers to generic development and to lower the cost of generic entry so that more of the generic medicines that the FDA approves are launched and reach patients.
2/14/19 - Alkermes Plc Reports Financial Results for the Year Ended Dec. 31, 2018 and Provides Financial Expectations for 2019
Alkermes plc today reported financial results for the year ended Dec. 31, 2018 and provided financial expectations for 2019.. Proprietary product net sales for VIVITROL and ARISTADA i were $132.7 million for the quarter, reflecting a 28% increase compared to the same period in the prior year. Net loss according to generally accepted accounting pr
2/14/19 - Biosimilars Market Is Expected to Boom with Top Key Players Amgen Inc, Biocon, Dr. Reddy's Laboratories, F. Hoffmann-La Roche, Celltrion, Samsung Bioepis: The Global Biosimilars Market size is expected to reach a value of USD 61.47 billion by 2025, a
Tokyo, Japan 02/14/2019 Recent trends suggest the Biosimilars Market is poised to grow rapidly in the near future just in time for the fast approaching tenth anniversary of the Affordable Care Act's Biologics Price Competition and Innovation Act of 2009.. Top Key Players:- Pfizer- Sandoz International GmbH- Teva Pharmaceuticals Industries-
2/14/19 - Branded Generics Market Foreseen to Grow at 7.3% CAGR by 2026: Increasing prevalence of chronic and lifestyle diseases expected to create demand for branded generics over the assessment period
Valley Cottage, NY 02/14/2019 Differential and innovative product strategies that are adopted by various multinational pharma companies have been fuelling the growth of branded generics market at a global scale. These strategies include establishing sustained local capabilities with the strong local talents, engaging in portfolio marketing,..
2/14/19 - Dicyclomine HCl Injection, USP- Now Available from Nexus Pharmaceuticals
Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration approval for Dicyclomine Hydrochloride Injection, USP in 20 mg/2mL vial, the generic equivalent to Bentyl . Dicyclomine HCl, USP, is currently listed on the American Society of Health-System Pharmacists' drug shortage list. The addition of Dicyclomine Injec
2/14/19 - Generic Drug Market Accounted for Around USD 200.20 Billion in 2015 and Is Expected to Reach Approximately USD 380.60 Billion by 2021: Global generic drug market to hit USD 380.60 billion by 2021, growing at 10.8 % CAGR between 2016 and 2021.
Sarasota, FL 02/13/2019 Pharmacology is the study of drugs and medicines, including their uses, effects, and characteristic. Generic drugs are chemically identical to their branded counterparts. It should be manufactured under the same rules and regulation of FDA's good manufacturing practice required for branded drugs.
2/14/19 - Perrigo Announces Patent Litigation Settlement for the Generic Version of Jublia Topical Solution 10%
DUBLIN- Perrigo Company plc, a leading global provider of' Quality, Affordable Self-care Products', today announced that it has settled its Hatch-Waxman litigation relating to its first-to-file Abbreviated New Drug Application for the generic equivalent to Jublia Topical Solution 10% brought by Valeant Pharmaceuticals North America LLC, Valeant...
2/14/19 - Pfizer Maintains Lead in ED Market
Pharmaceutical giant Pfizer holds a lead in the erectile dysfunction market even as competition from generics erodes sales of its once-blockbuster male libido treatment, Viagra. In its first quarter, Viagra brought a total of $400 million in revenue for Pfizer and would later produce annual sales of about $1.8 billion. U.S. sales of "the little blu
2/14/19 - Samsung Bioepis expands in China with second partner in two months [Tehran Times (Iran)]
Samsung Bioepis announces licensing agreement with C-Bridge to bring third-wave biosimilars to the Chinese market. The partnership will see Samsung Bioepis license biosimilar candidates to C-Bridge Capital, including SB11 and SB12 biosimilars to Lucentis and Soliris, respectively. C-Bridge is the right partner for this mission as evidenced in its..
2/14/19 - Specialty Generics Market Size and Key Trends in Terms of Volume and Value 2017-2027: Future Market Insights has announced the addition of the Specialty Generics Market: Global Industry Analysis and Opportunity Assessment 2017-2027 report to t
Valley Cottage, NY 02/13/2019 Specialty Generics are the generic versions of specialty pharmaceutical products. They are cost-effective when compared with specialty pharmaceuticals. For instance, in October 2016, Intellipharmaceutics entered into an exclusive license and supply agreement with Mallinckrodt to market, distribute, and sell its e
2/13/19 - Alembic Pharmaceuticals announces Orit Laboratories LLC receives USFDA Approval for Fenofibrate Tablets USP, 54 mg and 160 mg
Alembic Pharmaceuticals Limited today announced that its wholly owned step down subsidiary Orit Laboratories LLC has received approval from the US Food& Drug Administration for its Abbreviated New Drug Application Fenofibrate Tablets USP, 54 mg and 160 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Tricor..
2/13/19 - Alvogen and Lotus Launch the First Generic Equivalent to Revlimid? Capsules in Selected European Countries
Global pharmaceutical company, Alvogen, today announced the launch of the first generic equivalent of Revlimid? in a range of its operating CEE markets including Romania, Croatia, Bulgaria and the Baltic states. By the time of Alvogen launch, Revlimid? is perceived as the single biggest-selling oncology drug with approximately $9.8 billion sale
2/13/19 - Biosimilars Market Report (2018-2026) by Top Players: Pfizer, Amgen Inc, Biocon, F. Hoffmann-La Roche, Celltrion, Samsung Bioepis: A closer look at the overall Biosimilars business scenario presented through self-explanatory charts, tables, and graph
New York, NY 02/12/2019 The latest report on the Biosimilars market closely surveys, examines and offers vital statistics on the Biosimilars market for the forecast period 2018- 2026. This market intelligence assessment report weighs up on the potential region that reserves greater opportunities for this industry. The major players covered in
2/13/19 - Breckenridge Pharmaceutical, Inc. - Tetracycline launch announced
Boca Raton- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Tetracycline Capsules. The U.S. Food and Drug Administration had granted final approval for this Abbreviated New Drug Application on November 7, 2018. Breckenridge Pharmaceutical, Inc. is a privately-held own-label distributor that performs pharmaceutical...
2/13/19 - Dr. Reddy's Laboratories launches Tadalafil Tablets USP in the U.S. Market
Hyderabad- Dr. Reddy's Laboratories Ltd. today announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca Tablets in the United States market, approved by the U.S. Food and Drug Administration. Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovat
2/13/19 - FLAT Prices Act would help lower drug costs by punishing abusive pharmaceutical companies and limiting monopoly periods to encourage competition from generics. In Maine, prices for certain diabetes, cancer, and stroke medications rose between 25-40%
WASHINGTON As Maine people struggle with ever-increasing healthcare costs, Congressman Jared Golden introduced a bill today to help address unfair price hikes for prescription drugs. Representatives Sean Casten, Elissa Slotkin, Gil Cisneros, Max Rose, and Chellie Pingree cosponsored Golden's bill, the Forcing Limits on Abusive and Tumultuous Pric
2/13/19 - Global Generic Pharmaceutical Partnering Deals and Agreements Analysis 2012-2018
The "Global Generic Pharmaceutical Partnering Terms and Agreements 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com' s offering. Global Generic Pharmaceutical Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Generic...
2/13/19 - Lupin launches Tadalafil Tablets USP
Mumbai- Pharma major Lupin announced the launch of Tadalafil Tablets USP 20 mg, having received an approval from the United States Food and Drug Administration earlier. For the financial year ended 31st March, 2018, Lupin's Consolidated sales and Net profits before exceptional items were at Rs. 155,598 million and Rs. 13,934 million respectively.
2/13/19 - Lupin receives FDA approval for Fluoxetine Tablets USP
Mumbai- Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60 mg, from the United States Food and Drug Administration to market a generic version of Alvogen's Fluoxetine Tablets, 60 mg. Lupin's Fluoxetine Tablets USP, 60 mg, is the generic version of Alvogen's Fluoxetine Tablets, 60 mg. It is indicated in the
2/13/19 - Mylan Launches Wixela Inhub, the First Generic of ADVAIR DISKUS, at a List Price 70% Less than the Brand
HERTFORDSHIRE- Mylan N.V. today announced the launch of the first FDA- approved therapeutically equivalent, substitutable generic of ADVAIR DISKUS, Wixela Inhub, approved by the U.S. Food and Drug Administration through the Abbreviated New Drug Application pathway. The wholesale acquisition costs of Wixela Inhub 100 mcg/50 mcg, 250 mcg/50 mcg and 5
2/13/19 - Perrigo Announces Patent Litigation Settlement for the Generic Version of Jublia Topical Solution 10%
Perrigo Company plc, a leading global provider of "Quality, Affordable Self-care Products?", today announced that it has settled its Hatch-Waxman litigation relating to its first-to-file Abbreviated New Drug Application for the generic equivalent to Jublia Topical Solution 10% brought by Valeant Pharmaceuticals North America LLC, Valeant...
2/13/19 - Pharmaceutical Excipients Industry Size, Regional Overview, Sales Revenue, Key Players Analysis and Segments by Forecast to 2027
According to Market Research Future, the Global Pharmaceutical Excipients Market to provide readers with a clear view of the market's likely growth trajectory over the coming years. The report utilizes historical trends of the Global Pharmaceutical Excipients Market and present statistics to derive. Global Pharmaceutical Excipients Market will...
Articles(s): 1 - 25 of 59     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415